Loss of GATA3 in bladder cancer promotes cell migration and invasion

Yi Li1, Hitoshi Ishiguro2, Takashi Kawahara2

  • 1Department of Pathology and Laboratory Medicine; University of Rochester Medical Center; Rochester, NY USA; Department of Urology; 2nd Affiliated Hospital; Zhejiang University School of Medicine; Hangzhou, PR China.

Cancer Biology & Therapy
|January 23, 2014
PubMed

Insights

Loss of the transcription factor GATA3 promotes bladder cancer progression by increasing cell migration and invasion. GATA3 acts as a tumor suppressor, inhibiting metastasis and epithelial-to-mesenchymal transition in bladder cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • GATA3 is a transcription factor known as a breast tumor suppressor and urothelial marker.
  • Loss of GATA3 expression is frequently observed in high-grade invasive bladder cancer.
  • The specific functions of GATA3 within bladder cancer cells are not well understood.

Purpose of the Study:

  • To investigate the functional role of GATA3 in bladder cancer progression.
  • To assess the impact of GATA3 silencing on key cancer cell behaviors like migration, invasion, and proliferation.
  • To explore the molecular mechanisms underlying GATA3's function in bladder cancer.

Main Methods:

  • Utilized RNA interference (RNAi) to silence GATA3 expression in bladder cancer cell lines.
  • Quantified changes in cell migration and invasion assays.
  • Analyzed the expression and activity of key molecules involved in metastasis, including vascular endothelial growth factor (VEGF), matrix metalloproteinases (MMPs), N-cadherin, and β-catenin.
  • Performed experiments with enforced GATA3 expression in a bladder cancer cell line.

Main Results:

  • GATA3 expression was significantly downregulated in multiple bladder cancer cell lines compared to normal urothelial cells.
  • GATA3 knockdown led to increased cell migration and invasion, accompanied by elevated expression and activity of MMP-2 and MMP-9, and vascular endothelial growth factor.
  • GATA3 loss correlated with increased N-cadherin and decreased β-catenin, indicating promotion of epithelial-to-mesenchymal transition (EMT).
  • Enforced GATA3 expression suppressed migration and invasion, while GATA3 had minimal impact on cell viability, proliferation, cell cycle, or apoptosis.
  • Silencing GATA3 did not significantly affect migration in normal urothelial cells.

Conclusions:

  • GATA3 functions as a suppressor of bladder cancer progression and metastasis.
  • GATA3 inhibits bladder cancer cell migration, invasion, and epithelial-to-mesenchymal transition.
  • GATA3's tumor-suppressive role in bladder cancer is primarily mediated through the regulation of cell motility and EMT, rather than direct effects on proliferation or apoptosis.